Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Phase 1/2 × Vomiting × Palonosetron × Clear all

Phase

Phase 3 11 Phase 2 9 Phase 4 5 Phase NA 4 Phase 1/2 2 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 2

Sponsor

Cancer Type

Conditions

Vomiting 2 Weight Loss 1 Nausea 1 Melanoma 1 Anorexia 1

Interventions

Palonosetron 2 fosaprepitant 1 Neoadjuvant Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01046240 2015-01-27

Pharmacokinetic Evaluation of Subcutaneous Versus Intravenous Palonosetron in Cancer Treated With Chemotherapy

Clinica Universidad de Navarra, Universidad de Navarra

Phase 1/2 Completed

Vomiting

NCT00412425 2012-05-04

Palonosetron for Prevention of Biochemotherapy Induced Nausea and Vomiting

M.D. Anderson Cancer Center

Phase 1/2 Completed

30 enrolled 4 charts

Anorexia, Melanoma, Nausea, Vomiting, Weight Loss

Data powered by HemOnc (CC BY 4.0) Colophon ⚡